Skip to content
Hair Pipeline
← Remedies and supplements

Does zinc-thymulin spray help hair loss?

We found one study of zinc-thymulin on human hair, published in 2017. In it, 18 adults with pattern hair loss sprayed a 0.0005% solution on the scalp twice a day for 4 to 10 months, with no comparison group, and across all 18 their overall hair scores did not improve significantly. The paper reports a significant gain in the 11 treated for six months or more, but the test it names, run on its own table of scores, gives p = 0.22 for them rather than 0.045. Its author disclosed a financial interest and a patent application on zinc-thymulin, and we found no other study of it in people.

What the 2017 study did

The study enrolled 18 consecutive adults with pattern hair loss, 17 men and one woman aged 35 to 90, at grades 2 to 7 on the Norwood scale. They joined over six months and all stopped on the same date, so use lasted from 4 to 10 months. Each sprayed 1 to 2 ml of a water-based solution containing 0.0005% zinc-thymulin onto the scalp twice a day and rubbed it in. Three also used minoxidil, one of them with finasteride, and stayed in the results. Everyone got the spray, and there was no placebo or untreated group, so the study cannot say how the spray compares with doing nothing. Two trained assessors scored before-and-after phone photographs, de-identified and shown in pairs. The paper says the study followed the Declaration of Helsinki and good clinical practice guidelines, but it reports no trial registration and names no ethics committee.

What the paper reported

On a 0 to 10 score of overall hair, the change across all 18 people was not significant (p = 0.07). The paper reports a significant gain (p = 0.045) in the 11 treated for six months or more. For 10 of the 18, the photos were sharp enough to grade under magnification. In them, the share graded as absent hair fell (p = 0.008) and intermediate hairs, the grade between vellus and terminal hair, rose (p = 0.02); vellus and terminal hairs did not change significantly. One person had an hour of forehead redness after applying the spray following several hours in the sun and a facial scrub; the author put it down to the spray's citric acid buffer. The paper does not describe how side effects were looked for.

Recalculating the results

The paper prints every individual score, so its tests can be rerun. With the paired t-test it names, its table of overall scores gives p = 0.07 for all 18 people, as reported. For the 11 treated six months or more, the same test on the same table gives p = 0.22, not 0.045. Testing each assessor separately (0.49 and 0.31), one value per person (0.33) or a one-sided test (0.11) does not bring it under 0.05, and the five people treated more than six months, as the table's caption puts it, scored slightly lower on average after than before. The four hair-type results reproduce when both assessors' scores of the same photos count as separate pairs, as in the paper. The abstract's p < 0.0001 for new intermediate hairs cannot be checked: the tables hold percentage grades, not hair counts.

What thymulin is

Thymulin is a hormone made only by cells of the thymus gland. It is a chain of nine amino acids that becomes biologically active only when bound to zinc, and it has been studied for its role in the development of T cells of the immune system. The 2017 paper bases its idea on a 2012 laboratory study of human hair follicles, which it describes as showing that thymulin could extend the hair's growth phase. The spray is applied to the scalp, and its zinc is there to bind the thymulin; zinc taken by mouth is a separate question, covered on our zinc page. We found no other study of thymulin on hair in people, and neither ClinicalTrials.gov nor the ISRCTN registry lists a trial of it.

Patent and regulatory status

The author disclosed "a financial interest in this study" and an Australian patent application on zinc-thymulin, filed in June 2016. The paper has no funding statement. We found no entry for thymulin in Drugs@FDA, the US database of approved drugs, or in the European Medicines Agency's data on medicines authorised at EU level. In France, the public medicines database lists thymulin only in two homeopathic medicines, registered at dilutions from 4CH to 30CH; like all homeopathic medicines registered under a common name, they carry no therapeutic indication.

Related questions

Sources

  1. An Analysis of the Safety and Efficacy of Topical Zinc-Thymulin to treat Androgenetic Alopecia · Hair: Therapy & Transplantation, 2017
  2. The Thymus–Neuroendocrine Axis: Physiology, Molecular Biology, and Therapeutic Potential of the Thymic Peptide Thymulin · Annals of the New York Academy of Sciences, 2009 · PMID 19236333
  3. Thymic Peptides Differentially Modulate Human Hair Follicle Growth · Journal of Investigative Dermatology, 2012 · PMID 22402437
  4. Drugs@FDA Overview · US Food and Drug Administration (openFDA), 2026
  5. Download medicine data · European Medicines Agency, 2026
  6. Téléchargement · Base de données publique des médicaments (ANSM), 2026
  7. THYMULINE BOIRON, degré de dilution compris entre 4CH et 30CH ou entre 8DH et 60DH · Base de données publique des médicaments (ANSM), 2026
  8. THYMULINE LEHNING, degré de dilution compris entre 5CH et 30CH ou entre 9DH et 60DH · Base de données publique des médicaments (ANSM), 2026

Checked against its sources on 2026-11-01, by us, not by a doctor. A research register, not medical advice: talk to a dermatologist about your own case. See why we're not doctors.